Literature DB >> 23168256

T cell activation is driven by an ADP-dependent glucokinase linking enhanced glycolysis with mitochondrial reactive oxygen species generation.

Marcin M Kamiński1, Sven W Sauer, Marian Kamiński, Silvana Opp, Thorsten Ruppert, Paulius Grigaravičius, Przemysław Grudnik, Hermann-Josef Gröne, Peter H Krammer, Karsten Gülow.   

Abstract

Mitochondria-originating reactive oxygen species (ROS) control T cell receptor (TCR)-induced gene expression. Here, we show that TCR-triggered activation of ADP-dependent glucokinase (ADPGK), an alternative, glycolytic enzyme typical for Archaea, mediates generation of the oxidative signal. We also show that ADPGK is localized in the endoplasmic reticulum and suggest that its active site protrudes toward the cytosol. The ADPGK-driven increase in glycolytic metabolism coincides with TCR-induced glucose uptake, downregulation of mitochondrial respiration, and deviation of glycolysis toward mitochondrial glycerol-3-phosphate dehydrogenase(GPD) shuttle; i.e., a metabolic shift to aerobic glycolysis similar to the Warburg effect. The activation of respiratory-chain-associated GPD2 results in hyperreduction of ubiquinone and ROS release from mitochondria. In parallel, mitochondrial bioenergetics and ultrastructure are altered. Downregulation of ADPGK or GPD2 abundance inhibits oxidative signal generation and induction of NF-κB-dependent gene expression, whereas overexpression of ADPGK potentiates them.
Copyright © 2012 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23168256     DOI: 10.1016/j.celrep.2012.10.009

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  81 in total

1.  Inhibitors of ROS production by the ubiquinone-binding site of mitochondrial complex I identified by chemical screening.

Authors:  Adam L Orr; Deepthi Ashok; Melissa R Sarantos; Tong Shi; Robert E Hughes; Martin D Brand
Journal:  Free Radic Biol Med       Date:  2013-08-27       Impact factor: 7.376

2.  ROS-triggered phosphorylation of complex II by Fgr kinase regulates cellular adaptation to fuel use.

Authors:  Rebeca Acín-Pérez; Isabel Carrascoso; Francesc Baixauli; Marta Roche-Molina; Ana Latorre-Pellicer; Patricio Fernández-Silva; María Mittelbrunn; Francisco Sanchez-Madrid; Acisclo Pérez-Martos; Clifford A Lowell; Giovanni Manfredi; José Antonio Enríquez
Journal:  Cell Metab       Date:  2014-05-22       Impact factor: 27.287

Review 3.  Mitochondrial ROS in the prohypertensive immune response.

Authors:  Rafal R Nazarewicz; Sergey I Dikalov
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-05-08       Impact factor: 3.619

Review 4.  Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release.

Authors:  Dmitry B Zorov; Magdalena Juhaszova; Steven J Sollott
Journal:  Physiol Rev       Date:  2014-07       Impact factor: 37.312

Review 5.  Mitochondria are the powerhouses of immunity.

Authors:  Evanna L Mills; Beth Kelly; Luke A J O'Neill
Journal:  Nat Immunol       Date:  2017-04-18       Impact factor: 25.606

Review 6.  Mitochondrial control of immunity: beyond ATP.

Authors:  Manan M Mehta; Samuel E Weinberg; Navdeep S Chandel
Journal:  Nat Rev Immunol       Date:  2017-07-03       Impact factor: 53.106

Review 7.  Exploiting immunometabolism and T cell function for solid organ transplantation.

Authors:  Jennifer B Allocco; Maria-Luisa Alegre
Journal:  Cell Immunol       Date:  2020-02-19       Impact factor: 4.868

8.  Programmed death-1 controls T cell survival by regulating oxidative metabolism.

Authors:  Victor Tkachev; Stefanie Goodell; Anthony W Opipari; Ling-Yang Hao; Luigi Franchi; Gary D Glick; James L M Ferrara; Craig A Byersdorfer
Journal:  J Immunol       Date:  2015-05-13       Impact factor: 5.422

Review 9.  Metabolism of stromal and immune cells in health and disease.

Authors:  Bart Ghesquière; Brian W Wong; Anna Kuchnio; Peter Carmeliet
Journal:  Nature       Date:  2014-07-10       Impact factor: 49.962

Review 10.  Targeting Type 1 Diabetes: Selective Approaches for New Therapies.

Authors:  Daniel F Sheehy; Sean P Quinnell; Arturo J Vegas
Journal:  Biochemistry       Date:  2019-01-17       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.